Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 286.00
Bid: 286.50
Ask: 291.00
Change: 22.50 (8.54%)
Spread: 4.50 (1.571%)
Open: 262.00
High: 295.00
Low: 262.00
Prev. Close: 263.50
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Financial Officer

26 Nov 2021 07:00

RNS Number : 6555T
Synthomer PLC
26 November 2021
 

26th November 2021

 

Synthomer plc

 

Appointment of Chief Financial Officer

 

 

Synthomer plc ("Synthomer" or "the Company") today announces the appointment of Lily Liu as Chief Financial Officer (CFO). Lily will take up the role no later than 1 July 2022, succeeding Steve Bennett who announced in August 2021 that he would step down once a suitable successor was in place.

Lily is a highly experienced CFO with an impressive track record of building strong performing finance teams and creating business value through organic and inorganic growth. She has worked in the manufacturing and engineering sectors for over 20 years, and joins from Essentra plc, a FTSE 250 components and solutions business, where she has been CFO. Lily was previously CFO at Xaar plc, a UK listed inkjet technology developer, and Smiths Detection business, a division of Smiths Group plc. Lily was born in Beijing and holds a degree in Economics from the Shanghai University of International Business & Economics. She moved to Sydney, Australia where she completed an MBA and developed her career with an investment bank before joining the BOC group, with whom she had a varied and successful career and moved to work in the UK in 2003.

Lily is currently a Non-Executive Director and member of the Audit Committee of DCC plc, a FTSE 100 listed international sales, marketing and support services business.

Commenting, Michael Willome, Chief Executive Officer, said:

"I am delighted that Lily has accepted the Board's offer to join Synthomer as Chief Financial Officer. She has a proven track record as a CFO and brings wide international business experience, having worked in the UK, Australia and Asia. I look forward to working with her to continue delivering on Synthomer's value creation agenda. I would also like to thank Steve for his enormous contribution and commitment to the Company, and wish him every success for the future."

Lily Liu added:

"I am very pleased to be joining Synthomer at an exciting point in the Company's development following the acquisition of the Eastman Adhesives Resins business in 2022. I look forward to working with Michael and the team on delivering the integration benefits and building on the considerable success which Synthomer has achieved to date." 

There are no other details that are required to be disclosed under Listing Rule 9.6.13.

Remuneration

All remuneration arrangements for Lily are consistent with the terms of the Directors' Remuneration Policy approved by shareholders at the AGM in April 2020. Lily will receive a base salary of £440,000 per annum. She will receive a pension allowance in line with the UK workforce. Lily will participate in the current Executive Director Annual Bonus Plan, which has an annual award opportunity of 150% of base salary (one-third deferred into shares for two years). She will participate in the Synthomer Performance Share Plan with an annual award opportunity of 150% of base salary, subject to performance conditions measured over a three-year period, with an additional two years holding period. She will be eligible to participate in both schemes in 2022. Lily will be required to build a shareholding equal to 200% of annual basic salary.

Lily will be entitled to benefits in line with the Group's current policy. Lily's employment contract requires 12 months' notice of termination by her and the Company.

 

Further information

Tim Hughes, President, Corporate Development Tel: 01279 436211

Charles Armitstead, Teneo Tel: 07703 330 269

 

ENDS

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUVUBRAKUAUAA
Date   Source Headline
1st May 20247:00 amRNSDivestment of Compounds completed
25th Apr 20244:30 pmRNSDirector/PDMR Shareholding
25th Apr 20244:20 pmRNSDirector/PDMR Shareholding
17th Apr 202410:43 amRNSTender offer results
15th Apr 20247:00 amRNSDivestment of Compounds
12th Apr 20247:00 amRNSPricing of senior notes
9th Apr 20243:47 pmRNSPre Stabilisation Notice
9th Apr 20248:09 amRNSNotice of tender offer
9th Apr 20248:09 amRNSProposed offering of senior notes
28th Mar 20242:38 pmRNSDirector/PDMR Shareholding
28th Mar 20242:38 pmRNSDirector/PDMR Shareholding
28th Mar 20242:10 pmRNSAnnual Financial Report and Notice of AGM
12th Mar 20247:00 amRNSFinal Results
30th Jan 20247:00 amRNSTrading Statement
17th Jan 20242:58 pmRNSExternal Appointment
15th Nov 20237:00 amRNSTrading statement - Autumn 2023
3rd Nov 20232:54 pmRNSDirector/PDMR Shareholding
23rd Oct 20231:58 pmRNSDirector/PDMR Shareholding
18th Oct 20237:00 amRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20233:13 pmRNSHolding(s) in Company - CORRECTION
16th Oct 202312:06 pmRNSHolding(s) in Company
16th Oct 202312:03 pmRNSHolding(s) in Company
16th Oct 202311:57 amRNSHolding(s) in Company
16th Oct 20237:00 amRNSTotal Voting Rights
16th Oct 20237:00 amRNSPDMR and PCA Notification
13th Oct 20234:18 pmRNSHolding(s) in Company
13th Oct 202310:48 amRNSHolding(s) in Company
13th Oct 20237:00 amRNSResult of rump placing
12th Oct 20234:36 pmRNSResult of Equity Issue
12th Oct 202310:09 amRNSHolding(s) in Company
11th Oct 20239:39 amRNSHolding(s) in Company
11th Oct 20237:00 amRNSPDMR PCA Notification
10th Oct 20233:04 pmRNSHolding(s) in Company
10th Oct 202310:26 amRNSHolding(s) in Company
10th Oct 202310:26 amRNSHolding(s) in Company
9th Oct 20233:08 pmRNSHolding(s) in Company
9th Oct 20239:44 amRNSHolding(s) in Company
6th Oct 20231:56 pmRNSHolding(s) in Company
6th Oct 20238:53 amRNSHolding(s) in Company
5th Oct 20232:40 pmRNSDirector/PDMR Shareholding
5th Oct 202312:27 pmRNSHolding(s) in Company
2nd Oct 20232:22 pmRNSHolding(s) in Company
28th Sep 20237:00 amRNSAdmission of Nil Paid Rights
27th Sep 20237:00 amRNSDespatch of PALs
26th Sep 20237:00 amRNSCapital Reorganisation
25th Sep 20231:58 pmRNSResults of General Meeting
22nd Sep 20233:21 pmRNSAdditional Listing
7th Sep 20233:44 pmRNSPublication of a Prospectus
7th Sep 20237:00 amRNSRights Issue

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.